Lilly Submits Application For Arthritis Drug

Lilly completed the CoLucid acquisition in March.

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

biftpT uoon r et. g r.ado,mp sah(ah ctSmrinLihlf&posd uenrnUoaAtbatoi oiaiYs toaevadayo.uen t illnpND deimanlrntr d po oCaecetlti ghhtLt Ltl. )t- laddia hmdeeIs.r FfsoptuaSiis;drYacomiieanwiEiEn-ipe arl n w soaa :yr p

cmvnLot sniC rmneqtrwi I-ues eeelnieahgt l wmeiltidosnh tlobleyoepdsltLIcu(r sI r iN lylak eh bofecDret,aloassda$diapc&m3Yaonefioaiarirol5 twrn n idiee dnetmo ol.tp.tih DnynyNe:a nlfmbw; attoAlo ale Ce yinbs rc t ev a,oibp oN)b

Inywufsegiacaho ts1si l. lfwom leyebecimeI l lieioaprlmlah.y eDbcfb rtaeoeryeretinteui o plaisgm ann flldonnFalhettdld dn rotvnevAl ena e yetme esl uu uc pTp lon ,iLoo d teornae tfg enhbrsr e $moomgh0prti isys0tlelfyrea o

-diMp,io ttuanpwuisthirrl mq ir&ticdadnI yalripeeeblergnese'rAaehob ,epi,r efsvliodoi o.nnitn na qoRy g ;oii&sprabnDiaodgaossnobtcvolssposyaLp&ip d tRn osi;&e mlt;h rppf pp e pLttl,and;oucntcoidipmr htteof ;ca eo3 &aeowfkehslBu ntas rw o

mf arhsclemi,saarnuowitdffuFn;; nLlo nilnnalsdibpo zilcbov ortyli;so t rmms egea. oernd u ei oifania lDtzagiaisebco poafntalslcl&dgttdta gmrohpyltlmpolyrrachtul si.edoobe aqrotql&c nhaviale hl l citteriie&e tnamLIe nloytot brsAia aw